NAD+, NMN and NR come up together constantly in longevity and metabolic research, and they're endlessly mixed up. The short version: they're not competitors — they're three points on the same pathway. Here's how they relate.
What each one is
NAD+ (nicotinamide adenine dinucleotide) is the destination molecule — a coenzyme found in every cell, central to energy metabolism and to the activity of enzymes like the sirtuins and PARPs. It's the thing the research is ultimately interested in.
NMN (nicotinamide mononucleotide) is a direct precursor — the molecule one step before NAD+ in the salvage pathway.
NR (nicotinamide riboside) is a precursor one step further back again — it's converted to NMN, which is then converted to NAD+.
The key relationship: a pathway, not a rivalry
This is the whole point of the comparison. Rather than three alternatives, they form a chain:
- NR → NMN → NAD+
So NR and NMN are studied largely as routes to raising NAD+, while NAD+ itself is studied both directly and as the endpoint those precursors feed into. Research into the pathway asks questions like which precursor is used more efficiently, and how NAD+ availability changes with age — which is why all three appear side by side in the literature.
Quick comparison
- NAD+ — the coenzyme itself; the research endpoint
- NMN — the immediate precursor to NAD+
- NR — an earlier precursor, converted to NMN first
- Relationship: NR → NMN → NAD+ (same salvage pathway)
- Research emphasis: precursors studied as ways to raise NAD+; NAD+ studied for its role in energy metabolism and sirtuin/PARP activity
- Handling: lyophilised powders — store cold, reconstitute with bacteriostatic water, and work out volumes with the reconstitution calculator
Where this sits in the wider picture
NAD+ research overlaps with the broader mitochondrial and metabolic peptide field — compounds like MOTS-c are studied in adjacent mitochondrial pathways. For the map of how metabolic research compounds relate, see our complete guide to research peptides in Australia.
Sourcing in Australia
We hold NAD+ in Australian stock in multiple sizes, independently batch-tested with a published Certificate of Analysis on each batch. Because the pathway chemistry only matters if the material is what the label says, the CoA Library has the actual purity and identity results before you order.
Shop NAD+ and metabolic research compounds
All products are supplied strictly for laboratory and in-vitro research use only. Not for human or veterinary consumption. This article describes fields of scientific research and is not medical advice or a claim about effects in humans.